Avan received her BSc in Medical Sciences with a major in Biomedicine from Karolinska Institutet in 2015 performing her Bachelor’s thesis on cytotoxic T-cell proteomics and cancer immunotherapy. She joined the Pete Williams Lab in 2020 as an MSc student to explore NAD as a treatment target for age-related macular degeneration completing her thesis for an MSc in Forensic Science through the University of Uppsala. Avan is currently a product stability analyst at Cepheid.